LEADER 00000cam  2200805 a 4500 
001    ocm32397579  
003    OCoLC 
005    20141223135657.0 
008    950413s1996    paua     b    001 0 eng   
010       95017690 
016 7  9506742|2DNLM 
020    0781703328 
020    9780781703321 
035    (OCoLC)32397579 
040    DNLM/DLC|beng|cDLC|dNLM|dNOH|dBAKER|dNLGGC|dBTCTA|dLVB
       |dYDXCP|dZWZ|dDEBBG|dKLH|dGBVCP|dOCLCO|dWUM|dOCLCQ|dSTJ 
049    STJP 
050 00 R853.C55|bQ35 1996 
060 00 1996 A-224 
060 10 WA 30|bQ1027 1996 
082 00 615.5|220 
084    44.06|2bcl 
084    XC 2650|2rvk 
084    XC 2800|2rvk 
084    44.05|2bcl 
084    44.10|2bcl 
084    44.38|2bcl 
084    44.40|2bcl 
096    WA 30|bQ1 1996 
245 00 Quality of life and pharmacoeconomics in clinical trials /
       |ceditor, Bert Spilker. 
250    2nd ed. 
264  1 Philadelphia :|bLippincott-Raven,|c[1996] 
264  4 |c©1996 
300    xlv, 1259 pages :|billustrations ;|c29 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
500    Revised edition of: Quality of life assessment in clinical
       trials. c1990. 
504    Includes bibliographical references and index. 
505 2  Introduction to the field of quality of life trials -- 
       Standard scales, tests, and approaches to quality of life 
       assessments -- Specific scales, tests, and measures -- 
       Choosing and administering tests and treatments -- 
       Analyzing, interpreting, and presenting data -- Special 
       perspectives on quality of life issues -- Cross-cultural 
       and cross-national issues -- Health policy issues -- 
       Special populations to assess quality of life -- Specific 
       problems and diseases -- Pharmacoeconomics. 
520    A comprehensive reference for clinical investigators who 
       conduct quality of life assessments. The volume is divided
       into eleven sections: introduction to the field; standard 
       scales, tests, and approaches; specific scales, tests, and
       measures; choosing and administering tests and treatments;
       analyzing, interpreting, and presenting data; special 
       perspectives on quality of life issues; cross-cultural and
       cross-national issues; health policy issues; special 
       populations to assess quality of life; specific problems 
       and diseases; and pharmacoeconomics. 
650  0 Clinical trials|xSocial aspects. 
650  0 Quality of life|xEvaluation. 
650  7 Qualité vie.|2fmesh 
650  7 Essais cliniques comme sujet.|2fmesh 
650  7 Traitement médicamenteux|xÉconomie.|2fmesh 
650 07 Aufsatzsammlung.|2swd 
650 07 Bewertung.|2swd 
650 07 Lebensqualität.|2swd 
650 07 Medizin.|2swd 
650 12 Quality of Life. 
650 17 Kwaliteit van het bestaan.|2gtt 
650 17 Medisch onderzoek.|2gtt 
650 17 Gezondheid.|2gtt 
650 17 Metingen.|2gtt 
650 17 Geneesmiddelen.|2gtt 
650 22 Clinical Trials as Topic. 
650 22 Drug Therapy|xeconomics. 
653  0 Clinical trials|aSocial aspects 
653  0 Quality of life|aEvaluation 
653  2 Clinical Trials 
653  2 Drug Therapy / economics 
700 1  Spilker, Bert. 
730 0  Quality of life assessment in clinical trials. 
994    01|bSTJ